(Q72267732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

editorial

0 references

title

When a question has an answer: rationale for our early termination of the HEART Trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

2

C H Hennekens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

M A Pfeffer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1173-1175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

How should results from completed studies influence ongoing clinical trials? The CAFA Study experience.

25 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980753-X

10.1016/S0002-9149(99)80753-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7762508%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference